All Posts Tagged With: "MRX"
(SLTM) Solta Medical Reports LipoSonix Approval
Aesthetic laser treatments provider Solta Medical (SLTM) reported that Medicis Technologies Corporation, a unit of specialty pharmaceutical company Medicis Pharmaceutical Corporation (
(MRX) Medicis Pharmaceutical Sells LipoSonix Business
Medicis Pharmaceutical Corp. (MRX) recently announced to have entered into a ‘Stock Purchase Agreement’ with Solta Medical, Inc. (SLTM),...
(SLTM) Solta Medical Buying Medicis Unit
Aesthetic laser treatments provider Solta Medical (SLTM) has agreed to acquire Medicis Technologies Corporation, a unit of specialty pharmaceutical company Medicis Pharmaceutical Corporation...
(AGII) Company News for August 9, 2011 – Corporate Summary
• Share prices of America’s biggest bank, Bank of America Corp. (NYSE:BAC) fell 20.32% after a report in the New York Times said that American International Group, Inc. (NYSE:
9Aug2011 | vitalstocks | 0 comments | Continued(AGN) Allergan Beats – Revisits Guidance
Allergan, Inc.’s (AGN) second quarter 2011 earnings of 96 cents per share inched ahead of the Zacks Consensus Estimate by a penny and surpassed the company’s guidance range of 93 – 95 cents. Earnings...
(BAC) Company News for July 15, 2011 – Corporate Summary
• Share prices of ConocoPhillips (NYSE:COP) increased 1.63% after the board of directors authorized the division of the energy company into two publicly traded firms
• Maker of chips for mobiles, PC’s...
(AKAM) Stock Market News for February 11, 2011 – Market News
On Thursday, a late day rally helped the market to close almost flat following Egyptian President Hosni Mubarak’s speech. Though the President said he was not resigning, Mubarak will delegate powers to the Vice President. Earlier in the day markets fell after network equipment...
(AGN) Allergan Wins FDA Approval For Label Expansion on Botox
Allergan, Inc. (AGN) recently received good news with the US Food and Drug Administration (FDA) granting approval to Botox for the treatment of increased muscle stiffness in the elbow, wrist and fingers in...
(AGN) Allergan Beats The Street – Outlook Disappoints
Allergan, Inc. (AGN) reported fourth quarter earnings of 78 cents per share, a cent above the Zacks Consensus Estimate. While earnings increased 2.6% from the year-ago quarter, revenues increased 15.9% to...
(AGN) Allergan Beats Estimates – Raises Outlook
Allergan, Inc. (AGN) reported third quarter earnings of 70 cents per share, a cent above the Zacks Consensus Estimate and 7.7% above the year-ago earnings of 65 cents. We were pleased to see total revenues...
(AGN) Allergan Receives FDA Warning
On Aug. 21, Allergan, Inc. (AGN) received a warning letter from the U.S. Food and Drug Administration’s (FDA) Division of Drug Marketing, Advertising and Communications (DDMAC) regarding a misleading advertisement used by the company for its acne treatment...